ArticleBMC veterinary research2025
Glucose monitoring intelligent tracking system for remote glycemic assessment in diabetic dogs: a novel approach.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Optimizing glucose control is one of the primary goals of diabetes management. This study assessed the feasibility and accuracy of a remote real-time continuous glucose monitoring system (RT-CGMS) integrated with intelligent tracking in diabetic dogs. Seven Beagle dogs were monitored using interstitial sensors across different configurations: adhesive only, adhesive with protective garments, and garments combined with an innovative glucose monitoring approach for remote transmission. Sensor wear time was slightly longer with garments (8.2 ± 6.7 vs. 5.8 ± 3.1 days; P > 0.05). Valid data acquisition was significantly higher in the remote-monitoring group [95 (84, 96)] compared to Group 1 [67 (47, 78)] and Group 2 [76 (64, 80), P < 0.001 for both]. A strong correlation was found between RT-CGMS and PBGM measurements (r = 0.904). Calibration improved accuracy at glucose levels ≥ 5.5 mmol/L, reducing MARD from 28.5 to 14.5% and increasing Bland-Altman agreement from 48 to 67%. However, MAD slightly increased in the < 5.5 mmol/L range (2.2 to 2.7 mmol/L). Frequent hyperglycemia, high variability, and glucose excursions were observed. In conclusion, RT-CGMS with intelligent tracking improved data continuity and accuracy in diabetic dogs. Future research should focus on improving the system's sensitivity under hypoglycemic conditions and exploring its broader applications, including its role in enhancing in-hospital glucose management, utilizing big data to facilitate online diagnostics and offline follow-up care, providing guidance for daily glucose stabilization, enabling personalized veterinary services, and offering subscription-based health reports for pet owners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.